Prelude Capital Management, LLC Merit Medical Systems Inc Transaction History

Prelude Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$74.03 - $85.24 $246,075 - $283,337	3,324 New	3,324 $278,000
Q2 2022 Aug 15, 2022	SELL	$51.75 - $70.49 $27,375 - $37,289	-529 Reduced 11.46%	4,089 $222,000
Q1 2022 May 16, 2022	BUY	$52.65 - $66.52 $243,137 - $307,189	4,618 New	4,618 $307,000
Q4 2020 Feb 16, 2021	SELL	$42.16 - $58.11 $50,381 - $69,441	-1,195 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$40.13 - $49.82 $19,142 - $23,764	-477 Reduced 28.53%	1,195 $52,000
Q2 2020 Aug 14, 2020	BUY	$28.84 - $45.65 $48,220 - $76,326	1,672 New	1,672 $76,000
Q1 2020 May 15, 2020	SELL	$25.94 - $41.02 $50,349 - $79,619	-1,941 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$20.66 - $32.08 $40,101 - $62,267	1,941 New	1,941 $61,000
Q1 2019 May 15, 2019	SELL	$50.86 - $61.83 $10,273 - $12,489	-202 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$50.15 - $65.94 $10,130 - $13,319	202 New	202 $11,000

395

57.4M

901K

7.2K

Ticker MMSI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 56,919,400
Market Cap $6B
Description
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention produc...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.